[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @DermTimesNow Dermatology Times Dermatology Times posts on X about rpd, steak, bobs, psa the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::55642575/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX +498% - X Year XXXXXXX -XX% ### Mentions: X [#](/creator/twitter::55642575/posts_active)  - X Week XX -XX% - X Month XXX -XX% - X Months XXX +793% - X Year XXX +363% ### Followers: XXXXXX [#](/creator/twitter::55642575/followers)  - X Week XXXXXX +0% - X Month XXXXXX +0.11% - X Months XXXXXX +0.35% - X Year XXXXXX +0.64% ### CreatorRank: undefined [#](/creator/twitter::55642575/influencer_rank)  ### Social Influence [#](/creator/twitter::55642575/influence) --- **Social category influence** [stocks](/list/stocks) **Social topic influence** [rpd](/topic/rpd), [steak](/topic/steak), [bobs](/topic/bobs), [psa](/topic/psa), [longterm](/topic/longterm) ### Top Social Posts [#](/creator/twitter::55642575/posts) --- Top posts by engagements in the last XX hours "👥🎰🎲 Michelle Hure MD MS FCAP FAAD discussed her #dermNPPA conference presentation and her passion to increase awareness of the potential risks associated with "forever chemicals" especially since it is a relatively new threat. #DERM2025"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1948749525302006224) 2025-07-25 14:17:47 UTC 31.8K followers, XXX engagements "👥🏙👧 Lisa Swanson MD FAAD emphasized the dramatic expansion of treatment options for young dermatology patients and the evolving clinical considerations involved in their care. #SPD2025"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1948838159954907460) 2025-07-25 20:09:59 UTC 31.8K followers, XXX engagements "📖 A new meta-analysis confirms #abrocitinib significantly improves itch and lesion severity in moderate to severe atopic dermatitis with a dose-dependent response and manageable safety profile. #DermTwitter #AD #AtopicDerm"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947014682063053309) 2025-07-20 19:24:08 UTC 31.8K followers, XXX engagements "Were live at the #SPD2025 meeting and excited to spotlight one of our amazing partners PeDRA Stop by their table to learn more about their latest innovations in pediatric dermatology and learn more about their work on our website:"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1948857763234304062) 2025-07-25 21:27:53 UTC 31.8K followers, XXX engagements "🌟🗓 Explore the top X articles from Dermatology Times from the past week including insights on the latest clinical trials therapeutic updates and more. #Top5"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1945591769392910448) 2025-07-16 21:09:59 UTC 31.9K followers, XXX engagements "🚨 At #RAD2025 Galderma shared 104-week data showing #nemolizumab delivers lasting skin clearance itch relief and improved quality of life in moderate-to-severe #AD whether patients were new or experienced with the drug. #AtopicDermatitis #DermTwitter"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1933270073776504916) 2025-06-12 21:07:58 UTC 31.9K followers, 1025 engagements "🗓 Review our recap of news from last week including the FDA's RPD Designation of QRX003 for Netherton Syndrome Galderma's X new clinical trials of nemolizumab Allergan Aesthetics' sPMA for SKINVIVE by Juvderm and more. #TheWeeklyRoundup #DermTwitter"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1941558195702432072) 2025-07-05 18:02:00 UTC 31.8K followers, XXX engagements "Still time to register Join us Tuesday July XX in San Antonio for an exclusive small-group roundtable on atopic dermatitis care with John Browning MD. 🕕 XX PM CT 📍 Bobs Steak & Chop House 🔗"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1949062140377051545) 2025-07-26 11:00:00 UTC 31.8K followers, XXX engagements "👥🏙👧 Lawrence Schachner MD chair and professor emeritus at the University of Miami Department of Dermatology has been named the 2025 recipient of the Alvin H. Jacobs Award by the American Academy of Pediatrics Section on Dermatology. #SPD2025"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1948776887901163993) 2025-07-25 16:06:31 UTC 31.8K followers, XXX engagements "❗Yesterday Bristol Myers Squibbs sNDA for #deucravacitinib (#Sotyktu) in psoriatic arthritis was accepted by the FDA with a March 2026 PDUFA date. #Psoriasis #DermTwitter #PsA"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947704558819356935) 2025-07-22 17:05:28 UTC 31.8K followers, XXX engagements "🌟🗓 Explore the top X articles from Dermatology Times from the past week including insights on the latest clinical trials therapeutic updates and more. #Top5 #DermTwitter"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947417045227766228) 2025-07-21 22:02:59 UTC 31.9K followers, XXX engagements "👥🏔🌲 A poster highlighted a positive shift in weekly Urticaria Activity Score (UAS7) bands after long-term treatment with remibrutinib in patients with chronic spontaneous urticaria. #ElevateDerm2025"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1948421876373422391) 2025-07-24 16:35:49 UTC 31.8K followers, XXX engagements "❗Galderma has launched new phase X trials for #nemolizumab (#Nemluvio) targeting systemic sclerosis (#SSc) and chronic pruritus of unknown origin (#CPUO). #DermTwitter"  [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1940154541048987761) 2025-07-01 21:04:23 UTC 31.8K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@DermTimesNow Dermatology Times
Dermatology Times posts on X about rpd, steak, bobs, psa the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +498%
- X Year XXXXXXX -XX%
Mentions: X #
- X Week XX -XX%
- X Month XXX -XX%
- X Months XXX +793%
- X Year XXX +363%
Followers: XXXXXX #
- X Week XXXXXX +0%
- X Month XXXXXX +0.11%
- X Months XXXXXX +0.35%
- X Year XXXXXX +0.64%
CreatorRank: undefined #
Social Influence #
Social category influence stocks
Social topic influence rpd, steak, bobs, psa, longterm
Top Social Posts #
Top posts by engagements in the last XX hours
"👥🎰🎲 Michelle Hure MD MS FCAP FAAD discussed her #dermNPPA conference presentation and her passion to increase awareness of the potential risks associated with "forever chemicals" especially since it is a relatively new threat. #DERM2025"
@DermTimesNow on X 2025-07-25 14:17:47 UTC 31.8K followers, XXX engagements
"👥🏙👧 Lisa Swanson MD FAAD emphasized the dramatic expansion of treatment options for young dermatology patients and the evolving clinical considerations involved in their care. #SPD2025" @DermTimesNow on X 2025-07-25 20:09:59 UTC 31.8K followers, XXX engagements
"📖 A new meta-analysis confirms #abrocitinib significantly improves itch and lesion severity in moderate to severe atopic dermatitis with a dose-dependent response and manageable safety profile. #DermTwitter #AD #AtopicDerm" @DermTimesNow on X 2025-07-20 19:24:08 UTC 31.8K followers, XXX engagements
"Were live at the #SPD2025 meeting and excited to spotlight one of our amazing partners PeDRA Stop by their table to learn more about their latest innovations in pediatric dermatology and learn more about their work on our website:" @DermTimesNow on X 2025-07-25 21:27:53 UTC 31.8K followers, XXX engagements
"🌟🗓 Explore the top X articles from Dermatology Times from the past week including insights on the latest clinical trials therapeutic updates and more. #Top5" @DermTimesNow on X 2025-07-16 21:09:59 UTC 31.9K followers, XXX engagements
"🚨 At #RAD2025 Galderma shared 104-week data showing #nemolizumab delivers lasting skin clearance itch relief and improved quality of life in moderate-to-severe #AD whether patients were new or experienced with the drug. #AtopicDermatitis #DermTwitter" @DermTimesNow on X 2025-06-12 21:07:58 UTC 31.9K followers, 1025 engagements
"🗓 Review our recap of news from last week including the FDA's RPD Designation of QRX003 for Netherton Syndrome Galderma's X new clinical trials of nemolizumab Allergan Aesthetics' sPMA for SKINVIVE by Juvderm and more. #TheWeeklyRoundup #DermTwitter" @DermTimesNow on X 2025-07-05 18:02:00 UTC 31.8K followers, XXX engagements
"Still time to register Join us Tuesday July XX in San Antonio for an exclusive small-group roundtable on atopic dermatitis care with John Browning MD. 🕕 XX PM CT 📍 Bobs Steak & Chop House 🔗" @DermTimesNow on X 2025-07-26 11:00:00 UTC 31.8K followers, XXX engagements
"👥🏙👧 Lawrence Schachner MD chair and professor emeritus at the University of Miami Department of Dermatology has been named the 2025 recipient of the Alvin H. Jacobs Award by the American Academy of Pediatrics Section on Dermatology. #SPD2025" @DermTimesNow on X 2025-07-25 16:06:31 UTC 31.8K followers, XXX engagements
"❗Yesterday Bristol Myers Squibbs sNDA for #deucravacitinib (#Sotyktu) in psoriatic arthritis was accepted by the FDA with a March 2026 PDUFA date. #Psoriasis #DermTwitter #PsA" @DermTimesNow on X 2025-07-22 17:05:28 UTC 31.8K followers, XXX engagements
"🌟🗓 Explore the top X articles from Dermatology Times from the past week including insights on the latest clinical trials therapeutic updates and more. #Top5 #DermTwitter" @DermTimesNow on X 2025-07-21 22:02:59 UTC 31.9K followers, XXX engagements
"👥🏔🌲 A poster highlighted a positive shift in weekly Urticaria Activity Score (UAS7) bands after long-term treatment with remibrutinib in patients with chronic spontaneous urticaria. #ElevateDerm2025" @DermTimesNow on X 2025-07-24 16:35:49 UTC 31.8K followers, XXX engagements
"❗Galderma has launched new phase X trials for #nemolizumab (#Nemluvio) targeting systemic sclerosis (#SSc) and chronic pruritus of unknown origin (#CPUO). #DermTwitter" @DermTimesNow on X 2025-07-01 21:04:23 UTC 31.8K followers, XXX engagements